212 related articles for article (PubMed ID: 33500518)
1. Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs.
Béguin J; Gantzer M; Farine I; Foloppe J; Klonjkowski B; Maurey C; Quéméneur É; Erbs P
Sci Rep; 2021 Jan; 11(1):2209. PubMed ID: 33500518
[TBL] [Abstract][Full Text] [Related]
2. Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs.
Béguin J; Nourtier V; Gantzer M; Cochin S; Foloppe J; Balloul JM; Laloy E; Tierny D; Klonjkowski B; Quemeneur E; Maurey C; Erbs P
BMC Vet Res; 2020 Aug; 16(1):307. PubMed ID: 32843040
[TBL] [Abstract][Full Text] [Related]
3. First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells.
Minev BR; Lander E; Feller JF; Berman M; Greenwood BM; Minev I; Santidrian AF; Nguyen D; Draganov D; Killinc MO; Vyalkova A; Kesari S; McClay E; Carabulea G; Marincola FM; Butterfield LH; Szalay AA
J Transl Med; 2019 Aug; 17(1):271. PubMed ID: 31426803
[TBL] [Abstract][Full Text] [Related]
4. Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs.
LeBlanc AK; Naik S; Galyon GD; Jenks N; Steele M; Peng KW; Federspiel MJ; Donnell R; Russell SJ
Hum Gene Ther Clin Dev; 2013 Dec; 24(4):174-81. PubMed ID: 24219832
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors.
Béguin J; Laloy E; Cochin S; Gantzer M; Farine I; Pichon C; Moreau B; Foloppe J; Balloul JM; Machon C; Guitton J; Tierny D; Klonjkowski B; Quéméneur E; Maurey C; Erbs P
Mol Ther Oncolytics; 2023 Sep; 30():103-116. PubMed ID: 37635744
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer.
Béguin J; Foloppe J; Maurey C; Laloy E; Hortelano J; Nourtier V; Pichon C; Cochin S; Cordier P; Huet H; Quemeneur E; Klonjkowski B; Erbs P
Mol Ther Oncolytics; 2020 Dec; 19():57-66. PubMed ID: 33072863
[TBL] [Abstract][Full Text] [Related]
7. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
8. The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism.
Foloppe J; Kempf J; Futin N; Kintz J; Cordier P; Pichon C; Findeli A; Vorburger F; Quemeneur E; Erbs P
Mol Ther Oncolytics; 2019 Sep; 14():1-14. PubMed ID: 31011628
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.
Hwang CC; Igase M; Sakurai M; Haraguchi T; Tani K; Itamoto K; Shimokawa T; Nakaichi M; Nemoto Y; Noguchi S; Coffey M; Okuda M; Mizuno T
Vet Comp Oncol; 2018 Jun; 16(2):229-238. PubMed ID: 29076241
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma.
Gentschev I; Adelfinger M; Josupeit R; Rudolph S; Ehrig K; Donat U; Weibel S; Chen NG; Yu YA; Zhang Q; Heisig M; Thamm D; Stritzker J; Macneill A; Szalay AA
PLoS One; 2012; 7(5):e37239. PubMed ID: 22615950
[TBL] [Abstract][Full Text] [Related]
12. Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer.
Park SH; Breitbach CJ; Lee J; Park JO; Lim HY; Kang WK; Moon A; Mun JH; Sommermann EM; Maruri Avidal L; Patt R; Pelusio A; Burke J; Hwang TH; Kirn D; Park YS
Mol Ther; 2015 Sep; 23(9):1532-40. PubMed ID: 26073886
[TBL] [Abstract][Full Text] [Related]
13. Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma.
MacNeill AL; Weishaar KM; Séguin B; Powers BE
Viruses; 2018 Jul; 10(8):. PubMed ID: 30060548
[TBL] [Abstract][Full Text] [Related]
14. Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma.
Chintala NK; Choe JK; McGee E; Bellis R; Saini JK; Banerjee S; Moreira AL; Zauderer MG; Adusumilli PS; Rusch VW
Front Immunol; 2023; 14():1112960. PubMed ID: 36875061
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes.
Heinrich B; Klein J; Delic M; Goepfert K; Engel V; Geberzahn L; Lusky M; Erbs P; Preville X; Moehler M
Onco Targets Ther; 2017; 10():2389-2401. PubMed ID: 28496337
[TBL] [Abstract][Full Text] [Related]
16. Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter.
Haddad D; Chen CH; Carlin S; Silberhumer G; Chen NG; Zhang Q; Longo V; Carpenter SG; Mittra A; Carson J; Au J; Gonen M; Zanzonico PB; Szalay AA; Fong Y
PLoS One; 2012; 7(8):e41647. PubMed ID: 22912675
[TBL] [Abstract][Full Text] [Related]
17. A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer.
Manyam M; Stephens AJ; Kennard JA; LeBlanc J; Ahmad S; Kendrick JE; Holloway RW
Gynecol Oncol; 2021 Dec; 163(3):481-489. PubMed ID: 34686353
[TBL] [Abstract][Full Text] [Related]
18. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.
Yu YA; Galanis C; Woo Y; Chen N; Zhang Q; Fong Y; Szalay AA
Mol Cancer Ther; 2009 Jan; 8(1):141-51. PubMed ID: 19139123
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.
Autio K; Knuuttila A; Kipar A; Ahonen M; Parviainen S; Diaconu I; Kanerva A; Hakonen T; Vähä-Koskela M; Hemminki A
Vet Comp Oncol; 2016 Dec; 14(4):395-408. PubMed ID: 25302859
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic cancer therapy with a vaccinia virus strain.
Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B; Hu Z
Oncol Rep; 2019 Jan; 41(1):686-692. PubMed ID: 30365140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
